Pa. Xarelto Plaintiffs Request to Amend Master Complaint
Pa. Xarelto Plaintiffs Request to Amend Master Complaint
Introduction
More than 1,800 product liability claims involving Johnson & Johnson and its subsidiary Janssen Pharmaceuticals’ blood thinner Xarelto are awaiting trial in Philadelphia Court of Common Pleas, and trials for three Xarelto lawsuits are expected to begin this April.
A request to make changes to the Master Complaint was put before the Philadelphia Court of Common Pleas by the remaining Pennsylvania plaintiffs to give them time to “reorganize the allegations and provide more details about the actions and inactions that form the bases of already-existing causes of action.” This request is strongly opposed by the defendants.
There are nearly 18,000 Xarelto federal product liability claims consolidated under MDL No.- 2592 in the U.S. District Court for the Eastern District of Louisiana.
Comments
Latest News
NC to Get $150M to Boost Opioid Treatment, Recovery
Categories: Opioids
North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid…
SRI Gets FDA OK for High-Dose Naloxone Trial
Categories: Opioids
SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.
The approval was granted under an Investigational New Drug (IND)…
Spokane County to Get $5M in New Opioid Settlement
Categories: Opioids
Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.
The agreement addresses the company’s role in fueling…